Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT vs FOSPHENYTOIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAPREPITANT vs FOSPHENYTOIN: Safety Overview

Metric FOSAPREPITANT FOSPHENYTOIN
Total FAERS Reports 487 1,378
Deaths Reported 154 166
Death Rate 31.6% 12.0%
Hospitalizations 264 646
Average Patient Age 49.6 yrs 37.5 yrs
% Female Patients 83.0% 52.4%
FDA Approval Date N/A Aug 5, 1996
Manufacturer N/A Pfizer Laboratories Div Pfizer Inc
Route N/A INTRAMUSCULAR
Marketing Status N/A Prescription